Fig. 2From: Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluationa Tornado diagram, presenting incremental costs results of sensitivity analyses. b Tornado diagram, presenting incremental qalys results of sensitivity analysesBack to article page
